Gregory MD, Ofosu-Asante K, Lazarte JMS, Puente PE, et al. Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis. PLoS One 2024;19:e0312563.
PMID: 39436906